The United States Patent and Trademark Office (USPTO) has recorded an intent-to-use trademark application, identified as TM99715187, for the mark "RANATA THERAPEUTICS." This application was filed on March 20, 2026, and pertains to medical services, specifically including medical testing for diagnostic or treatment purposes, medical diagnostic testing, monitoring, and reporting services, and medical testing for diagnostic or treatment purposes in the field of cancer and oncology.

This filing represents a new trademark application and does not impose immediate compliance obligations on other entities. However, companies operating in the pharmaceutical and healthcare sectors, particularly those involved in cancer diagnostics and treatment, should be aware of this application as it may indicate future market activity or branding strategies by Ranata Therapeutics. No specific actions are required from compliance officers at this stage.